• Citer

Management of Aromatase Inhibitor-Associated Bone Loss (AIBL) in postmenopausal women with hormone sensitive breast cancer: Joint position statement of the IOF, CABS, ECTS, IEG, ESCEO IMS, and SIOG

par Hadji, Peyman;Baber, Rod;Roodman, G. David;Cooper, Cyrus;Langdahl, Bente;Palacios, Santiago;Kanis, John Anthony;Al-Daghri, Nasser;Nogues, Xavier;Eriksen, Erik Fink;Kurth, Andreas;Aapro, Matti;Rizzoli, René;Coleman, Robert;Body, Jean-Jacques ;Gnant, Michael;Brandi, Maria Luisa;Reginster, Jean-Yves;Zillikens, Maria Carola Carola M.C.;Glüer, Claus Christian;De Villiers, Tobie
Référence Journal of Bone Oncology, 7, page (1-12)
Publication Publié, 2017-06

Article révisé par les pairs

• Accès en ligne
• Détails
• Contenu
• Statistiques

Titre:	Management of Aromatase Inhibitor-Associated Bone Loss (AIBL) in postmenopausal women with hormone sensitive breast cancer: Joint position statement of the IOF, CABS, ECTS, IEG, ESCEO IMS, and SIOG
Auteur:	Hadji, Peyman; Baber, Rod; Roodman, G. David; Cooper, Cyrus; Langdahl, Bente; Palacios, Santiago; Kanis, John Anthony; Al-Daghri, Nasser; Nogues, Xavier; Eriksen, Erik Fink; Kurth, Andreas; Aapro, Matti; Rizzoli, René; Coleman, Robert; Body, Jean-Jacques; Gnant, Michael; Brandi, Maria Luisa; Reginster, Jean-Yves; Zillikens, Maria Carola Carola M.C.; Glüer, Claus Christian; De Villiers, Tobie
Informations sur la publication:	Journal of Bone Oncology, 7, page (1-12)
Statut de publication:	Publié, 2017-06
Sujet CREF:	Neurosciences cognitives
	Biopsychologie et psychopathologie
Mots-clés:	Bisphosphonate
	Breast cancer
	Denosumab
	Endocrine treatment
	Fracture
	Osteoporosis
Note générale:	SCOPUS: re.j
Langue:	Anglais
Identificateurs:	urn:issn:2212-1374
	info:doi/10.1016/j.jbo.2017.03.001
	info:pii/S2212137417300258
	info:scp/85017128778